Eisai and Biogen's Alzheimer's med Leqembi turned down in Europe
BMS gets Q2 beat, raises full-year guidance as cost-cutting initiative continues
Big Pharma appears to be unfazed by IRA drug price negotiations
Indivior reaches $86 million opioid settlement with US states
*please scroll down for all the latest news*
Check open job listings in your area
Click here to stay updated on CP happenings
learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud
BMS gets Q2 beat, raises full-year guidance as cost-cutting initiative continues
Big Pharma appears to be unfazed by IRA drug price negotiations
Indivior reaches $86 million opioid settlement with US states
*please scroll down for all the latest news*
Check open job listings in your area
Click here to stay updated on CP happenings
learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud